<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dehondt H</submitter><funding>European Research Council</funding><funding>Agence Nationale de la Recherche</funding><funding>Seventh Framework Programme</funding><funding>European Commission</funding><funding>European Commission Sixth Framework Programme</funding><pagination>101686</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9958065</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>69</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Obesity is associated with metabolic dysfunction of white adipose tissue (WAT). Activated adipocytes secrete pro-inflammatory cytokines resulting in the recruitment of pro-inflammatory macrophages, which contribute to WAT insulin resistance. The bile acid (BA)-activated nuclear Farnesoid X Receptor (FXR) controls systemic glucose and lipid metabolism. Here, we studied the role of FXR in adipose tissue function.&lt;h4>Methods&lt;/h4>We first investigated the immune phenotype of epididymal WAT (eWAT) from high fat diet (HFD)-fed whole-body FXR-deficient (FXR&lt;sup>-/-&lt;/sup>) mice by flow cytometry and gene expression analysis. We then generated adipocyte-specific FXR-deficient (Ad-FXR&lt;sup>-/-&lt;/sup>) mice and analyzed systemic and eWAT metabolism and immune phenotype upon HFD feeding. Transcriptomic analysis was done on mature eWAT adipocytes from HFD-fed Ad-FXR&lt;sup>-/-&lt;/sup> mice.&lt;h4>Results&lt;/h4>eWAT from HFD-fed whole-body FXR&lt;sup>-/-&lt;/sup> and Ad-FXR&lt;sup>-/-&lt;/sup> mice displayed decreased pro-inflammatory macrophage infiltration and inflammation. Ad-FXR&lt;sup>-/-&lt;/sup> mice showed lower blood glucose concentrations, improved systemic glucose tolerance and WAT insulin sensitivity and oxidative stress. Transcriptomic analysis identified Gsta4, a modulator of oxidative stress in WAT, as the most upregulated gene in Ad-FXR&lt;sup>-/-&lt;/sup> mouse adipocytes. Finally, chromatin immunoprecipitation analysis showed that FXR binds the Gsta4 gene promoter.&lt;h4>Conclusions&lt;/h4>These results indicate a role for the adipocyte FXR-GSTA4 axis in controlling HFD-induced inflammation and systemic glucose homeostasis.</pubmed_abstract><journal>Molecular metabolism</journal><pubmed_title>Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasis.</pubmed_title><pmcid>PMC9958065</pmcid><funding_grant_id>ANR-10-LABX-46</funding_grant_id><funding_grant_id>FP7-305707</funding_grant_id><funding_grant_id>FP6 Hepadip FP6-018734</funding_grant_id><funding_grant_id>694717</funding_grant_id><pubmed_authors>Nzoussi Loubota AC</pubmed_authors><pubmed_authors>Caron S</pubmed_authors><pubmed_authors>Lefebvre P</pubmed_authors><pubmed_authors>Bongiovanni A</pubmed_authors><pubmed_authors>Chavez-Talavera O</pubmed_authors><pubmed_authors>Vallez E</pubmed_authors><pubmed_authors>Dehondt H</pubmed_authors><pubmed_authors>Lestavel S</pubmed_authors><pubmed_authors>Staels B</pubmed_authors><pubmed_authors>Haas J</pubmed_authors><pubmed_authors>Derudas B</pubmed_authors><pubmed_authors>Butruille L</pubmed_authors><pubmed_authors>Marino A</pubmed_authors><pubmed_authors>Tardivel M</pubmed_authors><pubmed_authors>Tailleux A</pubmed_authors><pubmed_authors>Dombrowicz D</pubmed_authors><pubmed_authors>Dorchies E</pubmed_authors><pubmed_authors>Kuipers F</pubmed_authors><pubmed_authors>Mogilenko DA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasis.</name><description>&lt;h4>Objective&lt;/h4>Obesity is associated with metabolic dysfunction of white adipose tissue (WAT). Activated adipocytes secrete pro-inflammatory cytokines resulting in the recruitment of pro-inflammatory macrophages, which contribute to WAT insulin resistance. The bile acid (BA)-activated nuclear Farnesoid X Receptor (FXR) controls systemic glucose and lipid metabolism. Here, we studied the role of FXR in adipose tissue function.&lt;h4>Methods&lt;/h4>We first investigated the immune phenotype of epididymal WAT (eWAT) from high fat diet (HFD)-fed whole-body FXR-deficient (FXR&lt;sup>-/-&lt;/sup>) mice by flow cytometry and gene expression analysis. We then generated adipocyte-specific FXR-deficient (Ad-FXR&lt;sup>-/-&lt;/sup>) mice and analyzed systemic and eWAT metabolism and immune phenotype upon HFD feeding. Transcriptomic analysis was done on mature eWAT adipocytes from HFD-fed Ad-FXR&lt;sup>-/-&lt;/sup> mice.&lt;h4>Results&lt;/h4>eWAT from HFD-fed whole-body FXR&lt;sup>-/-&lt;/sup> and Ad-FXR&lt;sup>-/-&lt;/sup> mice displayed decreased pro-inflammatory macrophage infiltration and inflammation. Ad-FXR&lt;sup>-/-&lt;/sup> mice showed lower blood glucose concentrations, improved systemic glucose tolerance and WAT insulin sensitivity and oxidative stress. Transcriptomic analysis identified Gsta4, a modulator of oxidative stress in WAT, as the most upregulated gene in Ad-FXR&lt;sup>-/-&lt;/sup> mouse adipocytes. Finally, chromatin immunoprecipitation analysis showed that FXR binds the Gsta4 gene promoter.&lt;h4>Conclusions&lt;/h4>These results indicate a role for the adipocyte FXR-GSTA4 axis in controlling HFD-induced inflammation and systemic glucose homeostasis.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-05-29T22:24:17.792Z</modification><creation>2025-04-03T22:08:57.795Z</creation></dates><accession>S-EPMC9958065</accession><cross_references><pubmed>36746333</pubmed><doi>10.1016/j.molmet.2023.101686</doi></cross_references></HashMap>